Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Understanding the biology of triple-negative breast cancer.
Criscitiello C, Azim HA Jr, Schouten PC, Linn SC, Sotiriou C. Criscitiello C, et al. Ann Oncol. 2012 Aug;23 Suppl 6:vi13-8. doi: 10.1093/annonc/mds188. Ann Oncol. 2012. PMID: 23012296 Review.
Circulating tumor cells and emerging blood biomarkers in breast cancer.
Criscitiello C, Sotiriou C, Ignatiadis M. Criscitiello C, et al. Curr Opin Oncol. 2010 Nov;22(6):552-8. doi: 10.1097/CCO.0b013e32833de186. Curr Opin Oncol. 2010. PMID: 20706122 Review.
HER2-positive circulating tumor cells in breast cancer.
Ignatiadis M, Rothé F, Chaboteaux C, Durbecq V, Rouas G, Criscitiello C, Metallo J, Kheddoumi N, Singhal SK, Michiels S, Veys I, Rossari J, Larsimont D, Carly B, Pestrin M, Bessi S, Buxant F, Liebens F, Piccart M, Sotiriou C. Ignatiadis M, et al. PLoS One. 2011 Jan 10;6(1):e15624. doi: 10.1371/journal.pone.0015624. PLoS One. 2011. PMID: 21264346 Free PMC article.
Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection.
Criscitiello C, Fumagalli D, Saini KS, Loi S. Criscitiello C, et al. Onco Targets Ther. 2010 Dec 17;4:1-11. doi: 10.2147/OTT.S10155. Onco Targets Ther. 2010. PMID: 21552410 Free PMC article.
Targeting the subtypes of breast cancer: rethinking investigational drugs.
Curigliano G, Locatelli M, Fumagalli L, Brollo J, Munzone E, Nolé F, Criscitiello C, Goldhirsch A. Curigliano G, et al. Expert Opin Investig Drugs. 2012 Feb;21(2):191-204. doi: 10.1517/13543784.2012.651456. Epub 2012 Jan 10. Expert Opin Investig Drugs. 2012. PMID: 22229343 Review.
Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.
Azim HA Jr, Michiels S, Bedard PL, Singhal SK, Criscitiello C, Ignatiadis M, Haibe-Kains B, Piccart MJ, Sotiriou C, Loi S. Azim HA Jr, et al. Clin Cancer Res. 2012 Mar 1;18(5):1341-51. doi: 10.1158/1078-0432.CCR-11-2599. Epub 2012 Jan 18. Clin Cancer Res. 2012. PMID: 22261811
Further analyses suggested that breast cancer in the young is enriched with processes related to immature mammary epithelial cells (luminal progenitors, mammary stem, c-kit, RANKL) and growth factor signaling in two independent cohorts (n = 1,188 and 2,334). ...
Further analyses suggested that breast cancer in the young is enriched with processes related to immature mammary epithelial cells (luminal …
Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.
Ignatiadis M, Singhal SK, Desmedt C, Haibe-Kains B, Criscitiello C, Andre F, Loi S, Piccart M, Michiels S, Sotiriou C. Ignatiadis M, et al. J Clin Oncol. 2012 Jun 1;30(16):1996-2004. doi: 10.1200/JCO.2011.39.5624. Epub 2012 Apr 16. J Clin Oncol. 2012. PMID: 22508827
Targeted therapies in breast cancer: are heart and vessels also being targeted?
Criscitiello C, Metzger-Filho O, Saini KS, de Castro G Jr, Diaz M, La Gerche A, de Azambuja E, Piccart-Gebhart MJ. Criscitiello C, et al. Breast Cancer Res. 2012 Jun 19;14(3):209. doi: 10.1186/bcr3142. Breast Cancer Res. 2012. PMID: 22713170 Free PMC article. Review.
Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.
Criscitiello C, Azim HA Jr, Agbor-tarh D, de Azambuja E, Piccart M, Baselga J, Eidtmann H, Di Cosimo S, Bradbury I, Rubio IT. Criscitiello C, et al. Ann Oncol. 2013 Aug;24(8):1980-5. doi: 10.1093/annonc/mdt129. Epub 2013 Apr 7. Ann Oncol. 2013. PMID: 23567146 Clinical Trial.
106 results
Jump to page
Feedback